For research use only. Not for therapeutic Use.
Oxelumab（Cat No.:I042191）is an investigational monoclonal antibody that targets and inhibits the receptor CD200R1, which is involved in regulating immune responses. CD200R1 is expressed on immune cells and plays a role in suppressing inflammation, particularly in the tumor microenvironment and autoimmune diseases. By blocking CD200R1, oxelumab aims to enhance the immune system’s ability to recognize and attack cancer cells or reduce the immune suppression in autoimmune conditions. It is being studied in clinical trials for its potential to treat various cancers and autoimmune diseases, with a focus on improving patient outcomes.
| Catalog Number | I042191 |
| CAS Number | 1186098-83-8 |
| Purity | ≥95% |
